Mutual Advisors LLC Has $746,000 Holdings in Colgate-Palmolive (NYSE:CL)

Mutual Advisors LLC lessened its stake in Colgate-Palmolive (NYSE:CL) by 45.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,420 shares of the company’s stock after selling 6,947 shares during the quarter. Mutual Advisors LLC’s holdings in Colgate-Palmolive were worth $746,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. The Manufacturers Life Insurance Company boosted its holdings in shares of Colgate-Palmolive by 6.1% in the second quarter. The Manufacturers Life Insurance Company now owns 697,209 shares of the company’s stock valued at $67,657,000 after buying an additional 39,838 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in Colgate-Palmolive during the second quarter worth $2,125,000. Driehaus Capital Management LLC boosted its holdings in Colgate-Palmolive by 63.9% during the second quarter. Driehaus Capital Management LLC now owns 12,294 shares of the company’s stock worth $1,193,000 after purchasing an additional 4,792 shares during the last quarter. Ascent Group LLC boosted its holdings in Colgate-Palmolive by 10.1% during the second quarter. Ascent Group LLC now owns 14,022 shares of the company’s stock worth $1,361,000 after purchasing an additional 1,289 shares during the last quarter. Finally, Algert Global LLC boosted its holdings in Colgate-Palmolive by 14.4% during the second quarter. Algert Global LLC now owns 5,131 shares of the company’s stock worth $498,000 after purchasing an additional 647 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of several recent research reports. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. UBS Group dropped their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Price Performance

NYSE:CL opened at $87.88 on Monday. Colgate-Palmolive has a 52 week low of $80.03 and a 52 week high of $109.30. The firm has a market cap of $71.79 billion, a price-to-earnings ratio of 25.18, a P/E/G ratio of 3.59 and a beta of 0.44. The firm’s 50-day simple moving average is $91.81 and its 200 day simple moving average is $97.45. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.